$HLN Market Cap: $34.63 Billion
Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue
$11.23B
TTM
Gross Margin
61.49%
TTM
Net Earnings
$1.442B
TTM
Current Assets
$5.718B
Q4 2024
Current Liabilities
$5.812B
Q4 2024
Current Ratio
98.38%
Q4 2024
Total Assets
$34.32B
Q4 2024
Total Liabilities
$18.09B
Q4 2024
Book Value
$16.22B
Q4 2024
Cash
P/E
24.02
Nov 29, 2024 EST
Free Cash Flow
$1.983B
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019
Revenue $11.23B $11.30B $10.86B $9.545B $9.892B $8.480B
YoY Change -0.61% 4.09% 13.76% -3.51% 16.65%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019
Revenue $11.23B $11.30B $10.86B $9.545B $9.892B $8.480B
Cost Of Revenue $4.099B $4.344B $4.281B $3.561B $3.794B $3.249B
Gross Profit $6.824B $6.958B $6.577B $5.984B $6.098B $5.231B
Gross Profit Margin 60.75% 61.56% 60.57% 62.69% 61.65% 61.69%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operating Profits/Loss YoY Change

Operating Earnings to Gross Profit Ratio

Operating Profit Margin

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019
Selling, General & Admin $4.452B $4.097B $4.483B $3.567B $3.811B $3.349B
YoY Change 8.66% -8.61% 25.68% -6.4% 13.8%
% of Gross Profit 65.24% 58.88% 68.16% 59.61% 62.5% 64.02%
Research & Development $298.0M $297.0M $300.0M $256.0M $296.0M $267.0M
YoY Change 0.34% -1.0% 17.19% -13.51% 10.86%
% of Gross Profit 4.37% 4.27% 4.56% 4.28% 4.85% 5.1%
Depreciation & Amortization $324.0M $309.0M $287.0M $268.0M $305.0M $260.0M
YoY Change 4.85% 7.67% 7.09% -12.13% 17.31%
% of Gross Profit 4.75% 4.44% 4.36% 4.48% 5.0% 4.97%
Operating Expenses $4.750B $4.442B $4.752B $3.823B $4.107B $3.616B
YoY Change 6.93% -6.52% 24.3% -6.92% 13.58%
Operating Profit $2.074B $2.516B $1.825B $2.161B $1.991B $1.615B
YoY Change -17.57% 37.86% -15.55% 8.54% 23.28%
Operating Profit To Gross Profit 30.39% 36.16% 27.75% 36.11% 32.65% 30.87%
Operating Profit To Revenue 18.46% 22.26% 16.81% 22.64% 20.13% 19.04%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019
Interest Expense -$273.0M -$468.0M -$207.0M -$34.00M -$31.00M -$10.00M
YoY Change -41.67% 126.09% 508.82% 9.68% 210.0%
% of Operating Profit -13.16% -18.6% -11.34% -1.57% -1.56% -0.62%
Other Income/Expense, Net -$10.00M -$11.00M $52.00M -$3.000M -$5.000M -$4.000M
YoY Change -9.09% -121.15% -1833.33% -40.0% 25.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

No data

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019
Pretax Income $1.910B $1.628B $1.618B $1.636B $1.591B $886.0M
YoY Change 17.32% 0.62% -1.1% 2.83% 79.57%
Income Tax $435.0M $517.0M $499.0M $197.0M $410.0M $199.0M
% Of Pretax Income 22.77% 31.76% 30.84% 12.04% 25.77% 22.46%
Net Earnings $1.475B $1.049B $1.060B $1.390B $1.145B $655.0M
YoY Change 40.61% -1.04% -23.74% 21.4% 74.81%
Net Earnings / Revenue 13.13% 9.28% 9.76% 14.56% 11.58% 7.72%
Basic Earnings Per Share
Diluted Earnings Per Share $0.16 $0.11 $0.11 $150.5K $124.0K $70.93K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

No data

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019
Cash & Short-Term Investments $2.195B $1.044B $684.0M $347.0M $281.0M $323.0M
YoY Change 110.25% 52.63% 97.12% 23.49% -13.0%
Cash & Equivalents $684.0M $1.000M $1.000M $1.000M
Short-Term Investments $1.226B
Other Short-Term Assets $299.0M $526.0M $50.00M $128.0M $188.0M $283.0M
YoY Change -43.16% 952.0% -60.94% -31.91% -33.57%
Inventory $1.190B $1.408B $1.348B $951.0M $949.0M $1.211B
Prepaid Expenses
Receivables $1.588B $1.352B $1.487B $1.319B $1.349B $1.399B
Other Receivables $446.0M $488.0M $384.0M $2.506B $2.241B $2.595B
Total Short-Term Assets $5.718B $4.818B $4.059B $5.251B $5.008B $5.811B
YoY Change 18.68% 18.7% -22.7% 4.85% -13.82%
Property, Plant & Equipment $1.921B $1.902B $1.899B $1.662B $1.602B $1.621B
YoY Change 1.0% 0.16% 14.26% 3.75% -1.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $82.00M
YoY Change
Other Assets $383.0M $366.0M $421.0M $343.0M $302.0M $267.0M
YoY Change 4.64% -13.06% 22.74% 13.58% 13.11%
Total Long-Term Assets $28.60B $29.24B $30.76B $29.20B $29.12B $29.90B
YoY Change -2.19% -4.94% 5.33% 0.27% -2.6%
Total Assets $34.32B $34.06B $34.82B $34.45B $34.13B $35.71B
YoY Change
Accounts Payable $5.678B $1.855B $3.621B $1.369B $1.340B $1.201B
YoY Change 206.09% -48.77% 164.5% 2.16% 11.57%
Accrued Expenses $1.237B $1.276B $1.763B $1.412B $1.430B $1.436B
YoY Change -3.06% -27.62% 24.86% -1.26% -0.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $60.00M $0.00 $874.0M $348.0M $481.0M
YoY Change -100.0% -100.0% 151.15% -27.65%
Long-Term Debt Due $1.487B $596.0M $437.0M $30.00M $34.00M $40.00M
YoY Change 149.5% 36.38% 1356.67% -11.76% -15.0%
Total Short-Term Liabilities $5.812B $4.640B $4.370B $4.238B $4.014B $4.269B
YoY Change 25.26% 6.18% 3.11% 5.58% -5.97%
Long-Term Debt $8.640B $8.800B $10.00B $87.00M $105.0M $121.0M
YoY Change -1.82% -12.03% 11397.7% -17.14% -13.22%
Other Long-Term Liabilities $286.0M $399.0M $384.0M $289.0M $415.0M $395.0M
YoY Change -28.32% 3.91% 32.87% -30.36% 5.06%
Total Long-Term Liabilities $8.926B $9.199B $10.39B $376.0M $520.0M $516.0M
YoY Change -2.97% -11.44% 2662.5% -27.69% 0.78%
Total Liabilities $18.15B $17.45B $18.48B $8.096B $8.018B $8.390B
YoY Change 4.01% -5.6% 128.31% 0.97% -4.43%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

No data

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $34.634 Billion

About Haleon PLC

Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey. The company went IPO on 2022-07-18. The firm's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The firm's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Industry: Perfumes, Cosmetics & Other Toilet Preparations Peers: Alterola Biotech Inc